
life science companies that transform the lives of patients worldwide
Improving patients lives
(Nasdaq: AUPH, TSX: AUP)

life science companies that transform the lives of patients worldwide
Acquired by UCB

life science companies that transform the lives of patients worldwide
Building Better Biologics
(NYSE: ZYME)

Acquired by Gilead Sciences
$11.2B
life science companies that transform the lives of patients worldwide

life science companies that transform the lives of patients worldwide
The immune system preserved
(Nasdaq: GTHX)

ICIZED.
Acquired by Stryker
$1.65B
life science companies that transform the lives of patients worldwide

Severe Asthma
FORMED.
Acquired by Cephalon
$550 million
life science companies that transform the lives of patients worldwide
Lumira Ventures partners with exceptional entrepreneurs to build life science companies that transform the lives of patients worldwide.
Trending
2022 Lumira Venture Innovation Program Information (Lumira VIP)
March 14, 2022
The Venture Innovation Program is a 6-12 month program for Ph.D., MBA, and MD students across Canada who want to gain exposure to life sciences venture capital and start-ups, and are committed to... Learn More
Congruence Therapeutics Inc. Announces US$50 million Series A Financing to Advance Platform Targeting Diseases of Protein Misfolding
February 8, 2022
Congruence Therapeutics, a biotechnology company working at the interface of computational and experimental drug discovery to design novel small molecules for diseases of protein misfolding,... Learn More
Specific Biologics Closes Seed Financing with Industry Leaders Lumira Ventures and adMare BioInnovations
December 16, 2021
Specific Biologics Inc. (“Specific”) today announced that it has closed its first institutional financing, led by Lumira Ventures and adMare BioInnovations which have recently established an... Learn More
Lumira Co-Leads OncoMyx $50 Million Series B to Advance a Novel Immuno-Oncology Platform that Delivers Multiple Cancer-Killing Payloads
December 8, 2021
OncoMyx Therapeutics, a privately-held immuno-oncology platform company, today announced the closing of a $50 million Series B financing, co-led by Lumira Ventures and B Capital Group with... Learn More
Team Lumira
Our investment team of 12 professionals has over 225 years of collective experience founding, managing and investing in healthcare and life sciences companies. We value collaboration, creativity and challenging conventional wisdom.
Philanthropy
Lumira donates a portion of partner time and profits to support the research, translational medicine and healthcare access missions of over a dozen leading healthcare foundations.
Contact Us
Our team is strategically situated across North America to identify innovative companies within and outside the traditional start-up hubs, and help them access capital, talent and strategic partners.

Toronto
141 Adelaide Street
Suite 770
Toronto, ON
Canada, M5H 3L5
416.213.4223

Montreal
Espace CDPQ
3, Place Ville Marie
Bureau 12350, Niveau L
Montreal, QC
Canada, H3B 0E7
514.844.6927

Vancouver
1021 West Hastings Street,
9th floor
Vancouver, BC
Canada, V6E 0C3
604.558.5156

Boston
303 Wyman Street
Suite 300
Waltham, MA,
USA, 02451-1208
781.530.3868